Korean Biotech Sentiment Still Shaky But IPO Recovery Seen By Year-End

Investors Eye Upcoming SK Biopharm Float Next Year

 
• By Jung Won Shin
Going public
Korean Biotech IPOs Seen Picking Up • Source: Shutterstock

More from South Korea

More from Focus On Asia